Our results indicated that prophylactic insulin therapy in SENP1-deficient mice at the age of 5 weeks for 9 weeks only partially ameliorates development of diabetes phenotypes including immune cell infiltration, β-cell apoptosis and islet disruptions (Supplementary Fig. 7A–F). Here, INS is linked to diabetes mellitus.